BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16881059)

  • 1. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition.
    Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B
    J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
    Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
    Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.
    de Kruif J; Kramer A; Visser T; Clements C; Nijhuis R; Cox F; van der Zande V; Smit R; Pinto D; Throsby M; Logtenberg T
    J Mol Biol; 2009 Apr; 387(3):548-58. PubMed ID: 19361421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
    Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
    Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
    Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
    J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of chicken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV).
    Sapats SI; Heine HG; Trinidad L; Gould GJ; Foord AJ; Doolan SG; Prowse S; Ignjatovic J
    Arch Virol; 2003 Mar; 148(3):497-515. PubMed ID: 12607101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
    Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of immunoglobulin heavy and light chains to antibody specificity for lysozyme and two haptens.
    Smith-Gill SJ; Hamel PA; Lovoie TB; Dorrington KJ
    J Immunol; 1987 Dec; 139(12):4135-44. PubMed ID: 2447160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.
    Desiderio A; Franconi R; Lopez M; Villani ME; Viti F; Chiaraluce R; Consalvi V; Neri D; Benvenuto E
    J Mol Biol; 2001 Jul; 310(3):603-15. PubMed ID: 11439027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
    Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
    Winthrop MD; DeNardo SJ; Albrecht H; Mirick GR; Kroger LA; Lamborn KR; Venclovas C; Colvin ME; Burke PA; DeNardo GL
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of DNA by VH and Fv domains of an IgG anti-poly(dC) antibody with a singly mutated VH domain.
    O'Connor KC; Nguyen K; Stollar BD
    J Mol Recognit; 2001; 14(1):18-28. PubMed ID: 11180559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies.
    Sakai K; Shimizu Y; Chiba T; Matsumoto-Takasaki A; Kusada Y; Zhang W; Nakata M; Kojima N; Toma K; Takayanagi A; Shimizu N; Fujita-Yamaguchi Y
    Biochemistry; 2007 Jan; 46(1):253-62. PubMed ID: 17198396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies.
    Acierno JP; Braden BC; Klinke S; Goldbaum FA; Cauerhff A
    J Mol Biol; 2007 Nov; 374(1):130-46. PubMed ID: 17916365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the complex of the variable domain of antibody D1.3 and turkey egg white lysozyme: a novel conformational change in antibody CDR-L3 selects for antigen.
    Braden BC; Fields BA; Ysern X; Goldbaum FA; Dall'Acqua W; Schwarz FP; Poljak RJ; Mariuzza RA
    J Mol Biol; 1996 Apr; 257(5):889-94. PubMed ID: 8632472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.